Stay updated with breaking news from Lobe Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Quality Chemical Laboratories LLC ("QCL") has developed a synthetic pathway for psilocybin, psilocin and psilocin analogues exclusively for Lobe SciencesQCL agrees to supply Lobe Sciences research and
Vancouver, British Columbia--(Newsfile Corp. - February 10, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American Biopharmaceutical company committed to discovering
/PRNewswire/ -- Even during the recent global supply chain problems, certain markets have continued to show growth. The psychedelic drugs markets is one of...
Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED), which is focused on developing psychedelic-derived medicines for neurologic disease, revealed that it has signed...
Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED) said it expects to have two active Investigational New Drug applications in progress with the US Food and Drug...